Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life-Saving Therapies Network is a Canadian patient-led nonprofit and healthcare policy organization focused on accelerating access to promising therapies for people with lethal diseases. The organization brings together patients, oncologists, researchers, regulators, medical ethicists, health economists, and other stakeholders from North America and Europe. Its work centers on clinical research reform, regulatory reform, reimbursement reform, and patient education rather than proprietary drug development. LSTN publishes policy papers and educational materials, advocates for faster and more evidence-based approval pathways, and promotes adaptive and real-world trial approaches, particularly in oncology and other serious diseases. The group appears to operate as an active not-for-profit organization based in Ottawa, Canada.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Life-Saving Therapies Network.